2 options
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author.
- Series:
- United States. Congress. Senate. S. hrg. ; 114-805.
- S. hrg. ; 114-805
- Language:
- English
- Subjects (All):
- Prescription pricing--United States.
- Prescription pricing.
- Drugs--Law and legislation--United States.
- Drugs.
- Pharmaceutical industry--United States.
- Pharmaceutical industry.
- Competition--United States.
- Competition.
- Drug delivery devices--Prices--United States.
- Drug delivery devices.
- Drugs--Law and legislation.
- United States.
- Genre:
- Online resources.
- Legislative hearings.
- Physical Description:
- 1 online resource (iii, 43 pages) : illustrations.
- Other Title:
- How regulatory barriers inhibit pharmaceutical competition
- Place of Publication:
- Washington : U.S. Government Publishing Office, 2018.
- Notes:
- Includes bibliographical references.
- Description based on online resource; title from PDF title page (govinfo web site, viewed on December 14, 2018).
- Other Format:
- Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. EpiPen price increases
- OCLC:
- 1078951640
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.